According to Syros Pharmaceuticals
's latest financial reports the company's current revenue (TTM ) is HK$3 Million. In 2023 the company made a revenue of HK$77.59 Million a decrease over the revenue in the year 2022 that were of HK$0.11 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | HK$3.01 M | -96.11% |
2023 | HK$77.59 M | -33.26% |
2022 | HK$0.11 B | -36.52% |
2021 | HK$0.18 B | 56.52% |
2020 | HK$0.11 B | 658.04% |
2019 | HK$15.43 M | -3.85% |
2018 | HK$16.05 M | 86.62% |
2017 | HK$8.6 M | 249.93% |
2016 | HK$2.45 M | 0.05% |
2015 | HK$2.45 M |